-
Forest Laboratories (nyse: FRX - news - people ) has U.S. rights to the drug.
FORBES: Winning A Battle In The War On Stroke
-
In the past few years, Forest (nyse: FRX - news - people ) has been one of the drug industry's biggest success stories.
FORBES: Forest Bears Fruit
-
Among the largest underlying components of XPH, in trading today Jazz Pharmaceuticals Inc. ( JAZZ) is up about 5.4%, and Forest Labs Incorporated ( FRX) is up about 1.7%.
FORBES: Investors Are "Just Saying No" To Pharma ETF This Week
-
Reliant's Krivulka wholeheartedly agrees: He points to Forest Labs (nyse: FRX - news - people ) and its blockbuster antidepressant Celexa, which usurped much of Prozac's market share.
FORBES: How A Billionaire Clan Made Money In Biotech
-
The market for antidepressants is crowded, with entrants from Pfizer (nyse: PFE - news - people ) and Forest Laboratories (nyse: FRX - news - people ) taking up space.
FORBES: Magazine Article
-
According to Anderson's estimates, Pfizer will lose 41% of its sales between 2010 and 2012, more than any drug maker he covers except for much smaller Forest Laboratories (nyse: FRX - news - people ).
FORBES: Big Pharma's Black Hole
-
Among the largest underlying components of FXH, in trading today Lincare Holdings Inc. ( NASD: LNCR) is trading flat, Watson Pharmaceuticals, Inc. ( NYSE: WPI) is up about 0.3%, and Forest Laboratories, Inc. ( NYSE: FRX) is higher by about 0.7%.
FORBES: FXH, LNCR, WPI, FRX: ETF Outflow Alert
-
In its wake, similar drugs hit the market from Pfizer (nyse: PFE - news - people ), GlaxoSmithKline (nyse: GSK - news - people ) and Forest Laboratories (nyse: FRX - news - people ).
FORBES: With Drug Approval, Lilly Sighs Relief
-
In the past four years, AstraZeneca ( AZN), Pfizer ( PFE), Eli Lilly ( LLY), Bristol-Myers Squibb ( BMY) and Forest Labs ( FRX) have all settled federal charges of marketing psychoactive drugs off-label, at a cost running into hundreds of millions.
FORBES: Bad Side-Effects Ahead For Pharma?